In the treatment of tuberculosis, the therapeutic rationale for combination drug therapy is to:
1
Decrease cost and improve compliance.
2
Reduce the incidence of cumulative effects.
3
Increase blood dyscrasias.
4
Decrease emergence of drug-resistance strains.